MedTrace Logo

Artificial Oocyte Activation Comparing Tow Different Agents

NCT02424214 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2018-02-19

No results posted yet for this study

Summary

Comparing the efficacy of tow factors for artificial Oocyte Activation for poor quality Oocytes and Teratozoospermia patients.

Conditions

  • Oocyte Fertilization

Interventions

OTHER

Artificial Oocyte activation

DRUG

Ca Ionophore

DRUG

Strontium Chloride

Sponsors & Collaborators

  • Al Baraka Fertility Hospital

    collaborator OTHER

  • Banon IVF Center Assiut, Egypt

    collaborator OTHER

  • Ibn Sina Hospital

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Bahrain
  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02424214 on ClinicalTrials.gov